DK115547B - Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ<1,4>-pregnadien-3,20-dioner. - Google Patents

Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ<1,4>-pregnadien-3,20-dioner.

Info

Publication number
DK115547B
DK115547B DK45065AA DK45065A DK115547B DK 115547 B DK115547 B DK 115547B DK 45065A A DK45065A A DK 45065AA DK 45065 A DK45065 A DK 45065A DK 115547 B DK115547 B DK 115547B
Authority
DK
Denmark
Prior art keywords
pregnadiene
diones
fluor
acyloxy
methyl
Prior art date
Application number
DK45065AA
Other languages
Danish (da)
English (en)
Inventor
J Elks
E Bailey
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of DK115547B publication Critical patent/DK115547B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Details Of Garments (AREA)
DK45065AA 1964-01-28 1965-01-27 Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ<1,4>-pregnadien-3,20-dioner. DK115547B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3622/64A GB1070751A (en) 1964-01-28 1964-01-28 17-esters of 17-hydroxy-21-desoxy-steroids

Publications (1)

Publication Number Publication Date
DK115547B true DK115547B (da) 1969-10-20

Family

ID=9761806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK45065AA DK115547B (da) 1964-01-28 1965-01-27 Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ<1,4>-pregnadien-3,20-dioner.

Country Status (15)

Country Link
US (1) US3376193A (US06346242-20020212-C00066.png)
BE (1) BE658976A (US06346242-20020212-C00066.png)
BR (1) BR6566679D0 (US06346242-20020212-C00066.png)
CH (1) CH519489A (US06346242-20020212-C00066.png)
CY (1) CY554A (US06346242-20020212-C00066.png)
DE (1) DE1518915A1 (US06346242-20020212-C00066.png)
DK (1) DK115547B (US06346242-20020212-C00066.png)
ES (1) ES308634A1 (US06346242-20020212-C00066.png)
FR (2) FR5292M (US06346242-20020212-C00066.png)
GB (1) GB1070751A (US06346242-20020212-C00066.png)
IL (1) IL22809A (US06346242-20020212-C00066.png)
MY (1) MY7000161A (US06346242-20020212-C00066.png)
NL (1) NL144947B (US06346242-20020212-C00066.png)
NO (1) NO124689B (US06346242-20020212-C00066.png)
SE (1) SE318564B (US06346242-20020212-C00066.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153556B (da) * 1974-03-27 1988-07-25 Plurichemie Anstalt Fremgangsmaade til fremstilling af estere af 9alfa-klor- eller -fluor-16alfa- eller -16beta-metyl-21-desoxyprednisoloner

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1034011B (it) * 1969-06-26 1979-09-10 Vister Vismara Terapeutici S P Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato
US3789121A (en) * 1971-11-26 1974-01-29 Warner Lambert Co 17{60 ,21-orthobutyrates of 6{60 , 9{60 -difluoro-hydrocortisone and 6{60 , 9{60 -difluoroprednisolone, compositions containing same and the use thereof as anti-inflammatory agents
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
DE10302096B4 (de) * 2003-01-16 2005-03-17 Coty B.V. Kosmetische selbsterwärmende Produkte und deren Verwendung
AU2016210539B2 (en) 2015-01-19 2020-10-08 Council Of Scientific And Industrial Research A process for the preparation of corrosion resistant sealed anodized coatings on aluminum alloy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3115491A (en) * 1959-12-24 1963-12-24 Roussel Uclaf Process for the preparation of 11-substituted 17alpha, 21-dihydroxy-16alpha-methyl-9alpha-fluoro-delta1, 4-pregnadiene-3, 20-diones
DE1158507B (de) * 1960-10-29 1963-12-05 Merck Ag E Verfahren zur Herstellung von 6a-Methyl-16-methylen-steroiden
CH429716A (de) * 1961-06-24 1967-02-15 Vismara Francesco Spa Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden
US3104246A (en) * 1961-08-18 1963-09-17 Roussel Uclaf Process of preparation of beta-methasone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153556B (da) * 1974-03-27 1988-07-25 Plurichemie Anstalt Fremgangsmaade til fremstilling af estere af 9alfa-klor- eller -fluor-16alfa- eller -16beta-metyl-21-desoxyprednisoloner

Also Published As

Publication number Publication date
DE1793630B2 (de) 1975-10-23
FR5292M (US06346242-20020212-C00066.png) 1967-08-16
BE658976A (US06346242-20020212-C00066.png) 1965-07-28
NL144947B (nl) 1975-02-17
ES308634A1 (es) 1965-06-16
GB1070751A (en) 1967-06-01
DE1518915A1 (de) 1969-08-14
FR1472027A (fr) 1967-03-10
US3376193A (en) 1968-04-02
MY7000161A (en) 1970-12-31
NO124689B (US06346242-20020212-C00066.png) 1972-05-23
SE318564B (US06346242-20020212-C00066.png) 1969-12-15
NL6501123A (US06346242-20020212-C00066.png) 1965-07-29
CY554A (en) 1970-08-18
CH519489A (de) 1972-02-29
IL22809A (en) 1969-03-27
BR6566679D0 (pt) 1973-08-02
DE1793630A1 (de) 1971-07-08

Similar Documents

Publication Publication Date Title
DK116205B (da) Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK125553B (da) Fremgangsmåde til fremstilling af substituerede 2,4-diamino-5-benzylpyrimidiner.
DK106552C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner.
DK117631B (da) Fremgangsmåde til fremstilling af 20-oxopregnan-, 20-oxo-4-pregnen- eller 20-oxo-5(6)-pregnen-(17α, 16α-d)-oxazoliner.
DK117957B (da) Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener.
DK116441B (da) Fremgangsmåde til fremstilling af 10,11-dihydro-dibenzo-(b,f)-thiepinderivater.
DK123170B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 3-oxo-7α-methyl-Δ&lt;4,9,11&gt;-estratriener.
DK129126B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepiner.
DK115547B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK120752B (da) Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK108921C (da) Fremgangsmåde til fremstilling af tetrahydro-1,3,5-thiadiazin-2-thioner.
DK119107B (da) Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ&lt;4,9&gt;-gonadiener.
DK118557B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-11β-hydroxy-Δ&lt;4&gt;-pregnen-3,20-dioner.
DK112033B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkyl-17β-hydroxy-17α-ethinylgona-5(10),9(11)-diener.
DK114273B (da) Fremgangsmåde til fremstilling af α-methyl-α-amino-β-(3,4-disubstituerede-phenyl)-propionitriler.
DK116219B (da) Fremgangsmåde til fremstilling af 1,2,4-triazoler.
DK116294B (da) Analogifremgangsmåde til fremstilling af 4&#39;-demethyl-epipodophyllotoxin.
DK112031B (da) Fremgangsmåde til fremstilling af 3,20-dioxo-17α-methyl-19-nor-pregna-4,9,11-trien.
DK117420B (da) Analogifremgangsmåde til fremstilling af 12-oxygeneret-Δ&lt;3&gt;-A-norandrosten-2,17-dion.
DK106329C (da) Fremgangsmåde til fremstilling af 3,20-dioxo-19-nor-4,9,11-pregnatrien.
DK113917B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetrachlorcyclohexanon.
DK117955B (da) Analogifremgangsmåde til fremstilling af N&lt;4&gt;-acrylerede 1-halogenbenzen-2,4-disulfonamider.
DK109895C (da) Fremgangsmåde til fremstilling af 1,3-dioxo-2-alkyl-cyclopentaner.
DK114904B (da) Fremgangsmåde til fremstilling af 3,5-diiodthyroniner.
DK109639C (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-17α-methylestra-4,9,11-trien.